U.S. Markets closed

Biogen Inc. (BIIB)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
280.32-0.25 (-0.09%)
At close: 4:00PM EDT
People also watch
CELGREGNGILDAMGNALXN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue11,448,80010,763,8009,703,300
Cost of Revenue1,478,7001,240,4001,171,000
Gross Profit9,970,1009,523,4008,532,300
Operating Expenses
Research Development1,973,3002,012,8001,893,400
Selling General and Administrative1,972,9002,143,6002,193,400
Non Recurring487,90093,40093,400
Others385,600382,600489,800
Total Operating Expenses4,819,7004,632,400-
Operating Income or Loss5,150,4004,891,0003,972,400
Income from Continuing Operations
Total Other Income/Expenses Net-217,400-123,700-9,000
Earnings Before Interest and Taxes4,933,0004,767,3003,963,400
Interest Expense---
Income Before Tax4,933,0004,767,3003,963,400
Income Tax Expense1,237,3001,161,600989,900
Minority Interest-11,5002,1005,000
Net Income From Continuing Ops3,702,8003,547,0002,951,600
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,702,8003,547,0002,934,800
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares3,702,8003,547,0002,934,800